CompaniesBaccinex

Baccinex

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

80

By Phase

NA: 2

By Status

COMPLETED: 1UNKNOWN: 1

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT06594198Lead Sponsor

Evaluation of the BRAINDEX Brain Monitor in Cardiac Surgery, Interventional Comparative Study

40 participants

Started: Sep 9, 2024 · Completed: Mar 3, 2025

NCT05897060Lead Sponsor

Braindex Cerebral Tissue Oxygen Saturation (SctO2) Measurement Algorithm Assessment and Improvement

40 participants

Started: May 11, 2023 · Completed: Oct 30, 2023

Related Companies

Adragos Pharma

acquired